相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice
Marta Kruk-Slomka et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands
Marta Kruk-Slomka et al.
NEURAL PLASTICITY (2016)
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system
Marta Kruk-Slomka et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats
Somayeh Barzegar et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: The SHR strain
Valeria Almeida et al.
SCHIZOPHRENIA RESEARCH (2014)
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
Pilar Sanchez-Blazquez et al.
FRONTIERS IN PHARMACOLOGY (2014)
Leading compounds for the validation of animal models of psychopathology
Vincenzo Micale et al.
CELL AND TISSUE RESEARCH (2013)
Involvement of nitric oxide in granisetron improving effect on scopolamine-induced memory impairment in mice
Mehrak Javadi-Paydar et al.
BRAIN RESEARCH (2012)
Antipsychotic-like Effects of Cannabidiol and Rimonabant: Systematic Review of Animal and Human Studies
Patrik Roser et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia
Raquel Levin et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control
Maria Rodriguez-Munoz et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Enhanced MK-801-induced locomotion in Kir6.2 knockout mice
Yan Zhou et al.
NEUROSCIENCE RESEARCH (2012)
Suppression of nitric oxide synthesis by L-NAME reverses the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice
Nika Allami et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity
Robert E. Hampson et al.
NEUROPHARMACOLOGY (2011)
AM251, cannabinoids receptors ligand, improves recognition memory in rats
Izabela Bialuk et al.
PHARMACOLOGICAL REPORTS (2011)
WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction
Lianne Robinson et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Animal models of neuropsychiatric disorders
Eric J. Nestler et al.
NATURE NEUROSCIENCE (2010)
Effect of tandospirone, a serotonin-1A receptor partial agonist, on information processing and locomotion in dizocilpine-treated rats
Vera Bubenikova-Valesova et al.
PSYCHOPHARMACOLOGY (2010)
Signaling Pathways from Cannabinoid Receptor-1 Activation to Inhibition of N-Methyl-D-Aspartic Acid Mediated Calcium Influx and Neurotoxicity in Dorsal Root Ganglion Neurons
Qing Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats
Barbara Budzynska et al.
PHARMACOLOGICAL REPORTS (2009)
Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice
Grazyna Biala et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors
Vera Bubenikova-Valesova et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2008)
Arcaine and MK-801 make recall state-dependent in rats
Ana Paula Chiapinotto Ceretta et al.
PSYCHOPHARMACOLOGY (2008)
Neuropharmacological effects of oleamide in male and female mice
Moses A. Akanmu et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review
James M. Stone et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
Charles H. Large
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Opposing actions of chronic Delta 9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation
Alexander F. Hoffman et al.
LEARNING & MEMORY (2007)
NMDA receptor antagonism impairs reversal learning in developing rats
Kathryn K. Chadman et al.
BEHAVIORAL NEUROSCIENCE (2006)
Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats:: Role of glutamate in the nucleus accumbens
Zheng-Xiong Xi et al.
JOURNAL OF NEUROSCIENCE (2006)
WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors
FA Pamplona et al.
NEUROSCIENCE LETTERS (2006)
What causes the onset of psychosis?
MR Broome et al.
SCHIZOPHRENIA RESEARCH (2005)
The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze
RN Takahashi et al.
NEUROSCIENCE LETTERS (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity
LG Khaspekov et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Schizophrenia: From dopamine to glutamate and back
ML Carlsson et al.
CURRENT MEDICINAL CHEMISTRY (2004)
New perspectives in the studies on endocannabinoid and cannabis:: Abnormal behaviors associate with CB1 cannabinoid receptor and development of therapeutic application
M Fujiwara et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Glutamate receptor function in learning and memory
G Riedel et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse
SC Azad et al.
LEARNING & MEMORY (2003)
SR 141716A prevents Δ9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice
GE Da Silva et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Oleamide modulates memory in rats
E Murillo-Rodríguez et al.
NEUROSCIENCE LETTERS (2001)
Plasticity, hippocampal place cells, and cognitive maps
M Shapiro
ARCHIVES OF NEUROLOGY (2001)
Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception
E Palazzo et al.
NEUROPHARMACOLOGY (2001)
Catching up on schizophrenia: Natural history and neurobiology
DA Lewis et al.
NEURON (2000)
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
AH Lichtman
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids
JM Sullivan
LEARNING & MEMORY (2000)
分享论文
